• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国烟雾病症状表现的差异:一项全国性全支付方分析。

Disparities in the symptomatic presentation of Moyamoya disease in the United States: A nationwide all-payer analysis.

作者信息

Fuentes Angelica M, Chiu Ryan G, Mehta Ankit I

机构信息

Department of Neurosurgery, University of Illinois at Chicago, Chicago, IL 60612, USA.

Department of Neurosurgery, University of Illinois at Chicago, Chicago, IL 60612, USA.

出版信息

J Clin Neurosci. 2021 May;87:92-96. doi: 10.1016/j.jocn.2021.02.019. Epub 2021 Mar 20.

DOI:10.1016/j.jocn.2021.02.019
PMID:33863543
Abstract

BACKGROUND

Moyamoya disease is a chronic occlusive cerebrovascular disease that can present with either hemorrhagic or ischemic symptoms. The objective of this study was to evaluate whether the symptomatology of Moyamoya disease differs according to patient demographic groups.

METHODS

In this study, we used the Nationwide Inpatient Sample (NIS) to investigate differences in the presentation of Moyamoya disease by age group, gender, and ethnicity from 2012 to 2016. After propensity score matching was utilized to control for overall comorbidity, the matched cohorts for each symptomatology were compared using a Chi-square test with respect to the potential risk factors of interest (i.e. age, sex, ethnicity) in order to generate multivariate reported P-values.

RESULTS

A total of 4,474 patients met inclusion criteria. Patients presenting with ischemic stroke were more likely to be 65 years and older (p < 0.001); patients presenting with intracranial hemorrhage (ICH) were more likely to be 65 years and older (p < 0.001), male (p = 0.027), and Asian (p = 0.007); those presenting with seizure were more likely to be less than 10 years old (p = 0.002) and African American (p < 0.001); and those presenting with headache were more likely to be between 10 and 19 years old (p = 0.008).

CONCLUSIONS

Our findings demonstrate that the distinct presentations of Moyamoya are associated with patient age, gender, and race. This is the largest study of its kind and adds to the collective understanding of this rare but life-threatening condition.

摘要

背景

烟雾病是一种慢性闭塞性脑血管疾病,可表现为出血性或缺血性症状。本研究的目的是评估烟雾病的症状是否因患者人口统计学群体而异。

方法

在本研究中,我们使用全国住院患者样本(NIS)调查了2012年至2016年不同年龄组、性别和种族的烟雾病表现差异。在利用倾向评分匹配来控制总体合并症后,使用卡方检验比较每种症状的匹配队列在感兴趣的潜在风险因素(即年龄、性别、种族)方面的差异,以生成多变量报告的P值。

结果

共有4474名患者符合纳入标准。出现缺血性卒中的患者更可能年龄在65岁及以上(p<0.001);出现颅内出血(ICH)的患者更可能年龄在65岁及以上(p<0.001)、为男性(p=0.027)且为亚洲人(p=0.007);出现癫痫发作的患者更可能年龄小于10岁(p=0.002)且为非裔美国人(p<0.001);出现头痛的患者更可能年龄在10至19岁之间(p=0.008)。

结论

我们的研究结果表明,烟雾病的不同表现与患者年龄、性别和种族有关。这是同类研究中规模最大的一项,增加了对这种罕见但危及生命疾病的总体认识。

相似文献

1
Disparities in the symptomatic presentation of Moyamoya disease in the United States: A nationwide all-payer analysis.美国烟雾病症状表现的差异:一项全国性全支付方分析。
J Clin Neurosci. 2021 May;87:92-96. doi: 10.1016/j.jocn.2021.02.019. Epub 2021 Mar 20.
2
Epidemiological and clinical features of moyamoya disease in the USA.美国烟雾病的流行病学和临床特征。
Neuroepidemiology. 2013;40(4):282-7. doi: 10.1159/000345957. Epub 2013 Feb 23.
3
Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.美国人群中烟雾病及烟雾综合征患者脑微出血的患病率及危险因素
Cerebrovasc Dis Extra. 2019;9(3):139-147. doi: 10.1159/000504530. Epub 2019 Dec 12.
4
Thyroid Autoantibodies and the Clinical Presentation of Moyamoya Disease: A Prospective Study.甲状腺自身抗体与烟雾病的临床表现:一项前瞻性研究。
J Stroke Cerebrovasc Dis. 2018 May;27(5):1194-1199. doi: 10.1016/j.jstrokecerebrovasdis.2017.11.037. Epub 2018 Jan 2.
5
Nationwide survey on quasi-moyamoya disease in Japan.日本全国性烟雾病样疾病调查。
Acta Neurochir (Wien). 2014 May;156(5):935-40. doi: 10.1007/s00701-014-2013-0. Epub 2014 Feb 6.
6
High Prevalence of Moyamoya Syndrome in Appalachia.阿巴拉契亚地区 moyamoya 综合征的高发率。
Cerebrovasc Dis. 2020;49(5):516-521. doi: 10.1159/000510750. Epub 2020 Oct 7.
7
Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.烟雾病和烟雾病综合征:缺血性脑卒中预测因素的全国性住院患者研究。
J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105965. doi: 10.1016/j.jstrokecerebrovasdis.2021.105965. Epub 2021 Jul 8.
8
Moyamoya vasculopathy - Patient demographics and characteristics in the Finnish population.烟雾病血管病变——芬兰人群中的患者人口统计学和特征
Int J Stroke. 2017 Jan;12(1):90-95. doi: 10.1177/1747493016669847. Epub 2016 Sep 24.
9
Adult moyamoya disease in an urban center in the United States is associated with a high burden of watershed ischemia.美国一个城市中心的成人烟雾病与分水岭区缺血的高负担相关。
J Am Heart Assoc. 2014 Jul 18;3(4):e001123. doi: 10.1161/JAHA.114.001123.
10
Epidemiological features of moyamoya disease in Japan.日本烟雾病的流行病学特征。
Neurol Med Chir (Tokyo). 2012;52(5):295-8. doi: 10.2176/nmc.52.295.

引用本文的文献

1
The relationship between hemoglobin and triglycerides in moyamoya disease: A cross-sectional study.烟雾病中血红蛋白与甘油三酯的关系:一项横断面研究。
Front Neurol. 2022 Sep 8;13:994341. doi: 10.3389/fneur.2022.994341. eCollection 2022.